William C Weldon
Insider
First SEC filing: Jan. 19, 2016 · Latest: Jan. 19, 2016
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 8, 2026 | HTFL | M | 17,123 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| July 8, 2026 | HTFL | M | 17,123 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| July 8, 2026 | HTFL | M | 17,123 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| July 8, 2026 | HTFL | M | 17,123 | $8.33 | $142,635 | 243,931 Direct | +7.55% | Acquired | 492.1% (price as of 2026-10-02) |
| July 8, 2026 | HTFL | M | 17,123 | $8.33 | $142,635 | 226,808 Direct | +8.17% | Acquired | 492.1% (price as of 2026-10-02) |
| July 8, 2026 | HTFL | M | 17,123 | $8.33 | $142,635 | 209,685 Direct | +8.89% | Acquired | 492.1% (price as of 2026-10-02) |
| June 16, 2026 | HTFL | A | 16,075 | $32.05 | $515,204 | 16,075 Direct | · | Acquired | 53.9% (price as of 2026-10-02) |
| Aug. 11, 2025 | HTFL | C | 136,286 | · | · | 192,562 Direct | +242.17% | Acquired | (price as of 2026-10-02) |
| Aug. 11, 2025 | HTFL | C | 83,442 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Aug. 11, 2025 | HTFL | C | 25,160 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Aug. 11, 2025 | HTFL | C | 27,704 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Aug. 7, 2025 | HTFL | A | 23,710 | · | · | 23,710 Direct | · | Acquired | (price as of 2026-10-02) |
| Nov. 17, 2022 | CVS | A | 1,764 | $94.93 | $167,457 | 41,834 Direct | +4.40% | Acquired | -8.9% (price as of 2026-10-02) |
| May 11, 2022 | CVS | A | 1,760 | $97.99 | $172,462 | 39,397 Direct | +4.68% | Acquired | -11.8% (price as of 2026-10-02) |
| Nov. 17, 2021 | CVS | A | 1,672 | $92.73 | $155,045 | 37,361 Direct | +4.68% | Acquired | -6.8% (price as of 2026-10-02) |
| May 13, 2021 | CVS | A | 1,839 | $84.27 | $154,973 | 35,361 Direct | +5.49% | Acquired | 2.6% (price as of 2026-10-02) |
| Jan. 4, 2021 | XOM | A | 2,500 | · | · | 28,114 Direct | +9.76% | Acquired | |
| Nov. 18, 2020 | CVS | A | 2,336 | $66.35 | $154,994 | 33,075 Direct | +7.60% | Acquired | 30.3% (price as of 2026-10-02) |
| May 14, 2020 | CVS | A | 2,488 | $62.31 | $155,027 | 30,240 Direct | +8.97% | Acquired | 38.8% (price as of 2026-10-02) |
| March 9, 2020 | XOM | P | 4,591 | $43.56 | $199,984 | 35,538 Direct | +14.84% | Acquired | |
| March 6, 2020 | XOM | P | 4,180 | $48.09 | $201,016 | 30,947 Direct | +15.62% | Acquired | |
| Jan. 2, 2020 | XOM | A | 2,500 | · | · | 26,767 Direct | +10.30% | Acquired | |
| Nov. 20, 2019 | CVS | A | 2,069 | $74.92 | $155,009 | 27,319 Direct | +8.19% | Acquired | 15.4% (price as of 2026-10-02) |
| May 16, 2019 | CVS | A | 2,964 | $52.30 | $155,017 | 24,843 Direct | +13.55% | Acquired | 65.3% (price as of 2026-10-02) |
| March 31, 2019 | AMJB | A | 432 | $101.23 | $43,731 | 102,775 Direct | +0.42% | Acquired | -65.3% (price as of 2026-10-02) |
| Jan. 15, 2019 | AMJB | A | 2,487 | $100.54 | $250,043 | 101,565 Direct | +2.51% | Acquired | -65.1% (price as of 2026-10-02) |
| Jan. 2, 2019 | XOM | A | 2,500 | · | · | 24,209 Direct | +11.52% | Acquired | |
| Dec. 31, 2018 | AMJB | A | 474 | $97.62 | $46,272 | 99,079 Direct | +0.48% | Acquired | -64.0% (price as of 2026-10-02) |
| Nov. 7, 2018 | CVS | A | 1,777 | $78.77 | $139,974 | 21,525 Direct | +9.00% | Acquired | 9.8% (price as of 2026-10-02) |
| Sept. 30, 2018 | AMJB | A | 388 | $112.84 | $43,782 | 97,930 Direct | +0.40% | Acquired | -68.9% (price as of 2026-10-02) |
| June 30, 2018 | AMJB | A | 468 | $104.20 | $48,766 | 97,026 Direct | +0.48% | Acquired | -66.3% (price as of 2026-10-02) |
| June 4, 2018 | CVS | A | 2,184 | $64.10 | $139,994 | 19,464 Direct | +12.64% | Acquired | 34.9% (price as of 2026-10-02) |
| March 31, 2018 | AMJB | A | 443 | $109.97 | $48,717 | 96,072 Direct | +0.46% | Acquired | -68.1% (price as of 2026-10-02) |
| Jan. 16, 2018 | AMJB | A | 2,227 | $112.25 | $249,981 | 95,628 Direct | +2.38% | Acquired | -68.7% (price as of 2026-10-02) |
| Jan. 2, 2018 | XOM | A | 2,500 | · | · | 21,628 Direct | +13.07% | Acquired | |
| Dec. 31, 2017 | AMJB | A | 432 | $106.94 | $46,198 | 92,927 Direct | +0.47% | Acquired | -67.2% (price as of 2026-10-02) |
| Nov. 8, 2017 | CVS | A | 2,029 | $68.99 | $139,981 | 17,031 Direct | +13.52% | Acquired | 25.3% (price as of 2026-10-02) |
| Sept. 30, 2017 | AMJB | A | 537 | $95.51 | $51,289 | 91,970 Direct | +0.59% | Acquired | -63.2% (price as of 2026-10-02) |
| June 30, 2017 | AMJB | A | 506 | $91.40 | $46,248 | 90,953 Direct | +0.56% | Acquired | -61.6% (price as of 2026-10-02) |
| May 10, 2017 | CVS | A | 1,730 | $80.94 | $140,026 | 14,800 Direct | +13.24% | Acquired | 6.8% (price as of 2026-10-02) |
| March 31, 2017 | AMJB | A | 555 | $87.84 | $48,751 | 89,934 Direct | +0.62% | Acquired | -60.0% (price as of 2026-10-02) |
| Jan. 17, 2017 | AMJB | A | 2,967 | $84.25 | $249,970 | 89,379 Direct | +3.43% | Acquired | -58.3% (price as of 2026-10-02) |
| Jan. 3, 2017 | XOM | A | 2,500 | · | · | 19,118 Direct | +15.04% | Acquired | |
| Dec. 31, 2016 | AMJB | A | 493 | $86.29 | $42,541 | 85,939 Direct | +0.58% | Acquired | -59.3% (price as of 2026-10-02) |
| Nov. 2, 2016 | CVS | A | 1,668 | $83.95 | $140,029 | 12,904 Direct | +14.85% | Acquired | 3.0% (price as of 2026-10-02) |
| Sept. 30, 2016 | AMJB | A | 713 | $66.59 | $47,479 | 84,855 Direct | +0.85% | Acquired | -47.3% (price as of 2026-10-02) |
| June 30, 2016 | AMJB | A | 805 | $62.14 | $50,023 | 83,485 Direct | +0.97% | Acquired | -43.5% (price as of 2026-10-02) |
| May 19, 2016 | CVS | A | 1,387 | $100.95 | $140,018 | 11,128 Direct | +14.24% | Acquired | -14.4% (price as of 2026-10-02) |
| March 31, 2016 | AMJB | A | 887 | $59.22 | $52,528 | 82,076 Direct | +1.09% | Acquired | -40.7% (price as of 2026-10-02) |
| Jan. 19, 2016 | AMJB | A | 3,931 | $57.24 | $225,010 | 80,660 Direct | +5.12% | Acquired | -38.6% (price as of 2026-10-02) |
| Jan. 14, 2016 | 20171 | D | 4,393 | · | · | 0 Direct | -100.00% | Disposed | |
| Jan. 14, 2016 | 20171 | D | 3,559 | · | · | 0 Direct | -100.00% | Disposed | |
| Jan. 14, 2016 | 20171 | D | 1,042 | · | · | 0 Direct | -100.00% | Disposed | |
| Jan. 5, 2016 | 20171 | A | 14 | $131.55 | $1,842 | 3,559 Direct | +0.39% | Acquired | |
| Jan. 4, 2016 | XOM | A | 2,500 | · | · | 16,581 Direct | +17.75% | Acquired | |
| Jan. 1, 2016 | 20171 | A | 221 | $132.64 | $29,313 | 3,545 Direct | +6.65% | Acquired | |
| Dec. 31, 2015 | AMJB | A | 719 | $66.03 | $47,476 | 76,729 Direct | +0.95% | Acquired | -46.8% (price as of 2026-10-02) |
| Nov. 4, 2015 | CVS | A | 1,406 | $99.57 | $139,995 | 9,657 Direct | +17.04% | Acquired | -13.2% (price as of 2026-10-02) |
| Oct. 6, 2015 | 20171 | A | 14 | $123.39 | $1,727 | 3,324 Direct | +0.42% | Acquired | |
| Oct. 1, 2015 | 20171 | A | 261 | $122.10 | $31,868 | 3,309 Direct | +8.56% | Acquired | |
| Sept. 30, 2015 | AMJB | A | 779 | $60.97 | $47,496 | 75,483 Direct | +1.04% | Acquired | -42.4% (price as of 2026-10-02) |
| July 14, 2015 | 20171 | A | 13 | $121.86 | $1,584 | 3,048 Direct | +0.43% | Acquired | |
| July 1, 2015 | 20171 | A | 266 | $119.99 | $31,917 | 3,035 Direct | +9.61% | Acquired | |
| June 30, 2015 | AMJB | A | 738 | $67.76 | $50,007 | 74,227 Direct | +1.00% | Acquired | -48.2% (price as of 2026-10-02) |
| May 7, 2015 | CVS | A | 1,409 | $99.36 | $139,998 | 8,197 Direct | +20.76% | Acquired | -13.0% (price as of 2026-10-02) |
| April 28, 2015 | 20171 | A | 1,500 | $99.97 | $149,955 | 4,393 Direct | +51.85% | Acquired | |
| April 1, 2015 | 20171 | A | 340 | $101.11 | $34,377 | 2,756 Direct | +14.07% | Acquired | |
| April 1, 2015 | 20171 | A | 14 | $101.11 | $1,416 | 2,770 Direct | +0.51% | Acquired | |
| March 31, 2015 | AMJB | A | 825 | $60.58 | $49,978 | 73,014 Direct | +1.14% | Acquired | -42.0% (price as of 2026-10-02) |
| Jan. 20, 2015 | AMJB | A | 4,025 | $55.91 | $225,038 | 71,737 Direct | +5.94% | Acquired | -37.2% (price as of 2026-10-02) |
| Jan. 6, 2015 | 20171 | A | 11 | $100.58 | $1,106 | 2,416 Direct | +0.46% | Acquired | |
| Jan. 2, 2015 | XOM | A | 2,500 | · | · | 14,042 Direct | +21.66% | Acquired | |
| Jan. 1, 2015 | 20171 | A | 284 | $103.47 | $29,385 | 2,406 Direct | +13.38% | Acquired | |
| Dec. 31, 2014 | AMJB | A | 799 | $62.58 | $50,001 | 67,713 Direct | +1.19% | Acquired | -43.9% (price as of 2026-10-02) |
| Dec. 3, 2014 | 20171 | A | 58 | $103.43 | $5,999 | 2,122 Direct | +2.81% | Acquired | |
| Nov. 5, 2014 | CVS | A | 1,600 | $87.50 | $140,000 | 6,741 Direct | +31.12% | Acquired | -1.2% (price as of 2026-10-02) |
| Oct. 21, 2014 | 20171 | A | 21 | $94.02 | $1,974 | 2,064 Direct | +1.03% | Acquired | |
| Oct. 7, 2014 | 20171 | A | 10 | $92.06 | $921 | 2,042 Direct | +0.49% | Acquired | |
| Oct. 1, 2014 | 20171 | A | 248 | $90.77 | $22,511 | 2,033 Direct | +13.89% | Acquired | |
| Sept. 30, 2014 | AMJB | A | 789 | $60.24 | $47,529 | 66,480 Direct | +1.20% | Acquired | -41.7% (price as of 2026-10-02) |
| Sept. 3, 2014 | 20171 | A | 65 | $92.10 | $5,986 | 1,785 Direct | +3.78% | Acquired | |
| July 22, 2014 | 20171 | A | 22 | $92.17 | $2,028 | 1,720 Direct | +1.30% | Acquired | |
| July 15, 2014 | 20171 | A | 8 | $94.04 | $752 | 1,698 Direct | +0.47% | Acquired | |
| July 1, 2014 | 20171 | A | 243 | $92.75 | $22,538 | 1,690 Direct | +16.79% | Acquired | |
| June 30, 2014 | AMJB | A | 824 | $57.62 | $47,479 | 65,242 Direct | +1.28% | Acquired | -39.0% (price as of 2026-10-02) |
| June 11, 2014 | 20171 | A | 43 | $93.39 | $4,016 | 1,448 Direct | +3.06% | Acquired | |
| June 10, 2014 | 20171 | A | 21 | $93.94 | $1,973 | 1,405 Direct | +1.52% | Acquired | |
| May 8, 2014 | CVS | A | 1,846 | $75.86 | $140,038 | 5,106 Direct | +56.63% | Acquired | 14.0% (price as of 2026-10-02) |
| April 29, 2014 | 20171 | A | 1,414 | $91.88 | $129,918 | 2,893 Direct | +95.61% | Acquired | |
| April 29, 2014 | 20171 | A | 22 | $91.88 | $2,021 | 1,384 Direct | +1.62% | Acquired | |
| April 1, 2014 | 20171 | A | 239 | $88.73 | $21,206 | 1,356 Direct | +21.40% | Acquired | |
| April 1, 2014 | 20171 | A | 6 | $88.73 | $532 | 1,122 Direct | +0.54% | Acquired | |
| March 31, 2014 | AMJB | A | 782 | $60.71 | $47,475 | 64,019 Direct | +1.24% | Acquired | -42.2% (price as of 2026-10-02) |
| Feb. 27, 2014 | 20171 | A | 23 | $87.14 | $2,004 | 1,116 Direct | +2.10% | Acquired | |
| Feb. 10, 2014 | 20171 | A | 24 | $84.99 | $2,040 | 1,093 Direct | +2.25% | Acquired | |
| Jan. 28, 2014 | 20171 | A | 23 | $86.95 | $2,000 | 1,070 Direct | +2.20% | Acquired | |
| Jan. 22, 2014 | AMJB | A | 3,888 | $57.88 | $225,037 | 62,864 Direct | +6.59% | Acquired | -39.3% (price as of 2026-10-02) |
| Jan. 7, 2014 | 20171 | A | 4 | $93.20 | $373 | 1,047 Direct | +0.38% | Acquired | |
| Jan. 2, 2014 | XOM | A | 2,500 | · | · | 11,514 Direct | +27.73% | Acquired | |
| July 22, 2013 | AMJB | L | 0 | $56.56 | · | 58,563 Direct | 0.00% | Acquired | -37.9% (price as of 2026-10-02) |
Showing latest 100 of 340 transactions
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| July 8, 2026 | HTFL | Stock Option | Common Stock | $8.33 | Sept. 20, 2027 | 17,123 | Disposed |
| July 8, 2026 | HTFL | Stock Option | Common Stock | $8.33 | April 22, 2030 | 17,123 | Disposed |
| July 8, 2026 | HTFL | Stock Option | Common Stock | $8.33 | March 24, 2032 | 17,123 | Disposed |
| June 16, 2026 | HTFL | Stock Option | Common Stock | $32.05 | June 16, 2036 | 16,075 | Acquired |
| Aug. 11, 2025 | HTFL | Series D Preferred Stock | Common Stock | · | · | 83,442 | Disposed |
| Aug. 11, 2025 | HTFL | Series F Preferred Stock | Common Stock | · | · | 25,160 | Disposed |
| Aug. 11, 2025 | HTFL | Series F-1 Preferred Stock | Common Stock | · | · | 27,704 | Disposed |
| Aug. 7, 2025 | HTFL | Stock Option | Common Stock | $19.00 | Aug. 7, 2035 | 23,710 | Acquired |
| Nov. 17, 2022 | CVS | Share Credits | Common Stock | $0.00 | · | 1,764 | Acquired |
| May 11, 2022 | CVS | Share Credits | Common Stock | $0.00 | · | 1,760 | Acquired |
| Nov. 17, 2021 | CVS | Share Credits | Common Stock | $0.00 | · | 1,672 | Acquired |
| May 13, 2021 | CVS | Share Credits | Common Stock | $0.00 | · | 1,839 | Acquired |
| Nov. 18, 2020 | CVS | Share Credits | Common Stock | $0.00 | · | 2,336 | Acquired |
| May 14, 2020 | CVS | Share Credits | Common Stock | $0.00 | · | 2,488 | Acquired |
| Nov. 20, 2019 | CVS | Share Credits | Common Stock | $0.00 | · | 2,069 | Acquired |
| May 16, 2019 | CVS | Share Credits | Common Stock | $0.00 | · | 2,964 | Acquired |
| Nov. 7, 2018 | CVS | Share Credits | Common Stock | $0.00 | · | 1,777 | Acquired |
| June 4, 2018 | CVS | Share Credits | Common Stock | $0.00 | · | 2,184 | Acquired |
| Nov. 8, 2017 | CVS | Share Credits | Common Stock | $0.00 | · | 2,029 | Acquired |
| May 10, 2017 | CVS | Share Credits | Common Stock | $0.00 | · | 1,730 | Acquired |
| Nov. 2, 2016 | CVS | Share Credits | Common Stock | $0.00 | · | 1,668 | Acquired |
| May 19, 2016 | CVS | Share Credits | Common Stock | $0.00 | · | 1,387 | Acquired |
| Jan. 14, 2016 | 20171 | STOCK UNITS DEFERRED | Common Shares | · | · | 4,393 | Disposed |
| Jan. 14, 2016 | 20171 | MARKET VALUE UNITS | Common Shares | · | · | 3,559 | Disposed |
| Jan. 5, 2016 | 20171 | MARKET VALUE UNITS [F1] | Common Shares | · | · | 14 | Acquired |
| Jan. 1, 2016 | 20171 | MARKET VALUE UNITS [F1] | Common Shares | · | · | 221 | Acquired |
| Nov. 4, 2015 | CVS | Share Credits | Common Stock | $0.00 | · | 1,406 | Acquired |
| Oct. 6, 2015 | 20171 | MARKET VALUE UNITS [F1] | Common Shares | · | · | 14 | Acquired |
| Oct. 1, 2015 | 20171 | MARKET VALUE UNITS [F1] | Common Shares | · | · | 261 | Acquired |
| July 14, 2015 | 20171 | MARKET VALUE UNITS [F1] | Common Shares | · | · | 13 | Acquired |
| July 1, 2015 | 20171 | MARKET VALUE UNITS [F1] | Common Shares | · | · | 266 | Acquired |
| May 7, 2015 | CVS | Share Credits | Common Stock | $0.00 | · | 1,409 | Acquired |
| April 28, 2015 | 20171 | STOCK UNITS DEFERRED [F1] | Common Shares | · | · | 1,500 | Acquired |
| April 1, 2015 | 20171 | MARKET VALUE UNITS [F1] | Common Shares | · | · | 340 | Acquired |
| April 1, 2015 | 20171 | MARKET VALUE UNITS [F1] | Common Shares | · | · | 14 | Acquired |
| Jan. 6, 2015 | 20171 | MARKET VALUE UNITS [F1] | Common Shares | · | · | 11 | Acquired |
| Jan. 1, 2015 | 20171 | MARKET VALUE UNITS [F1] | Common Shares | · | · | 284 | Acquired |
| Dec. 3, 2014 | 20171 | MARKET VALUE UNITS [F1] | Common Shares | · | · | 58 | Acquired |
| Nov. 5, 2014 | CVS | Share Credits | Common Stock | $0.00 | · | 1,600 | Acquired |
| Oct. 21, 2014 | 20171 | MARKET VALUE UNITS [F1] | Common Shares | · | · | 21 | Acquired |
| Oct. 7, 2014 | 20171 | MARKET VALUE UNITS [F1] | Common Shares | · | · | 10 | Acquired |
| Oct. 1, 2014 | 20171 | MARKET VALUE UNITS [F1] | Common Shares | · | · | 248 | Acquired |
| Sept. 3, 2014 | 20171 | MARKET VALUE UNITS [F1] | Common Shares | · | · | 65 | Acquired |
| July 22, 2014 | 20171 | MARKET VALUE UNITS [F1] | Common Shares | · | · | 22 | Acquired |
| July 15, 2014 | 20171 | MARKET VALUE UNITS [F1] | Common Shares | · | · | 8 | Acquired |
| July 1, 2014 | 20171 | MARKET VALUE UNITS [F1] | Common Shares | · | · | 243 | Acquired |
| June 11, 2014 | 20171 | MARKET VALUE UNITS [F1] | Common Shares | · | · | 43 | Acquired |
| June 10, 2014 | 20171 | MARKET VALUE UNITS [F1] | Common Shares | · | · | 21 | Acquired |
| May 8, 2014 | CVS | Share Credits | Common Stock | $0.00 | · | 1,846 | Acquired |
| April 29, 2014 | 20171 | STOCK UNITS DEFERRED [F3] | Common Shares | · | · | 1,414 | Acquired |
| April 29, 2014 | 20171 | MARKET VALUE UNITS [F1] | Common Shares | · | · | 22 | Acquired |
| April 1, 2014 | 20171 | MARKET VALUE UNITS [F1] | Common Shares | · | · | 239 | Acquired |
| April 1, 2014 | 20171 | MARKET VALUE UNITS [F1] | Common Shares | · | · | 6 | Acquired |
| Feb. 27, 2014 | 20171 | MARKET VALUE UNITS [F1] | Common Shares | · | · | 23 | Acquired |
| Feb. 10, 2014 | 20171 | MARKET VALUE UNITS [F1] | Common Shares | · | · | 24 | Acquired |
| Jan. 28, 2014 | 20171 | MARKET VALUE UNITS [F1] | Common Shares | · | · | 23 | Acquired |
| Jan. 7, 2014 | 20171 | MARKET VALUE UNITS [F1] | Common Shares | · | · | 4 | Acquired |
| Jan. 1, 2014 | 20171 | MARKET VALUE UNITS [F1] | Common Shares | · | · | 194 | Acquired |
| Dec. 5, 2013 | 20171 | MARKET VALUE UNITS [F1] | Common Shares | · | · | 21 | Acquired |
| Dec. 4, 2013 | 20171 | MARKET VALUE UNITS [F1] | Common Shares | · | · | 42 | Acquired |
| Nov. 6, 2013 | CVS | Share Credits | Common Stock | $0.00 | · | 1,527 | Acquired |
| Oct. 22, 2013 | 20171 | MARKET VALUE UNITS [F1] | Common Shares | · | · | 21 | Acquired |
| Oct. 8, 2013 | 20171 | MARKET VALUE UNITS [F1] | Common Shares | · | · | 3 | Acquired |
| Oct. 1, 2013 | 20171 | MARKET VALUE UNITS [F1] | Common Shares | · | · | 210 | Acquired |
| Sept. 4, 2013 | 20171 | MARKET VALUE UNITS [F1] | Common Shares | · | · | 24 | Acquired |
| Sept. 3, 2013 | 20171 | MARKET VALUE UNITS [F1] | Common Shares | · | · | 48 | Acquired |
| July 23, 2013 | 20171 | MARKET VALUE UNITS [F1] | Common Shares | · | · | 23 | Acquired |
| July 9, 2013 | 20171 | MARKET VALUE UNITS [F1] | Common Shares | · | · | 1 | Acquired |
| July 1, 2013 | 20171 | MARKET VALUE UNITS [F1] | Common Shares | · | · | 220 | Acquired |
| June 5, 2013 | 20171 | MARKET VALUE UNITS [F1] | Common Shares | · | · | 47 | Acquired |
| June 4, 2013 | 20171 | MARKET VALUE UNITS [F1] | Common Shares | · | · | 23 | Acquired |
| May 9, 2013 | CVS | Share Credits | Common Stock | $0.00 | · | 1,696 | Acquired |
| April 30, 2013 | 20171 | STOCK UNITS DEFERRED [F3] | Common Shares | · | · | 1,479 | Acquired |
| April 30, 2013 | 20171 | MARKET VALUE UNITS [F1] | Common Shares | $0.00 | · | 23 | Acquired |
| April 30, 2013 | 20171 | MARKET VALUE UNITS [F1] | Common Shares | · | · | 142 | Acquired |
| Feb. 8, 2013 | JNJ | Restricted Share Units | Common Stock | · | · | 48,906 | Disposed |
| Dec. 13, 2012 | JNJ | Employee Stock Option (Right to Buy) [F2] | Common Stock | $66.18 | Feb. 13, 2015 | 1,510 | Disposed |
| Sept. 7, 2012 | JNJ | Employee Stock Option (Right to Buy) [F5] | Common Stock | $53.93 | Feb. 7, 2014 | 323,150 | Disposed |
| Feb. 1, 2012 | JNJ | Employee Stock Option (Right to Buy) [F3] | Common Stock | $52.20 | Feb. 8, 2013 | 448,085 | Disposed |
| Jan. 17, 2012 | JNJ | Performance Share Units [F3] | Common Stock | · | · | 114,182 | Acquired |
| Jan. 17, 2012 | JNJ | Restricted Share Units [F3] | Common Stock | · | · | 45,673 | Acquired |
| Jan. 17, 2012 | JNJ | Employee Stock Option (Right to Buy) [F3] | Common Stock | $65.37 | Jan. 17, 2022 | 628,911 | Acquired |
| Oct. 31, 2011 | JNJ | Employee Stock Option (Right to Buy) [F3] | Common Stock | $57.30 | Feb. 10, 2012 | 298,300 | Disposed |
| May 3, 2011 | JNJ | Employee Stock Option (Right to Buy) [F3] | Common Stock | $57.30 | Feb. 10, 2012 | 300,000 | Disposed |
| Feb. 11, 2011 | JNJ | Restricted Share Units | Common Stock | · | · | 43,320 | Disposed |
| Feb. 2, 2011 | JNJ | Employee Stock Option (Right to Buy) [F2] | Common Stock | $53.93 | Feb. 7, 2014 | 1,850 | Disposed |
| Feb. 2, 2011 | JNJ | Employee Stock Option (Right to Buy) [F2] | Common Stock | $52.20 | Feb. 8, 2013 | 1,915 | Disposed |
| Feb. 2, 2011 | JNJ | Employee Stock Option (Right to Buy) [F2] | Common Stock | $57.30 | Feb. 10, 2012 | 1,700 | Disposed |
| Jan. 10, 2011 | JNJ | Restricted Share Units [F4] | Common Stock | · | · | 46,724 | Acquired |
| Jan. 10, 2011 | JNJ | Employee Stock Option (Right to Buy) [F4] | Common Stock | $62.20 | Jan. 10, 2021 | 560,691 | Acquired |
| Sept. 2, 2010 | JNJ | Employee Stock Option (Right to Buy) [F4] | Common Stock | · | Nov. 29, 2010 | 238,100 | Disposed |
| Aug. 2, 2010 | JNJ | Employee Stock Option (Right to Buy) [F5] | Common Stock | · | Nov. 29, 2010 | 1,900 | Disposed |
| Feb. 12, 2010 | JNJ | Restricted Share Units | Common Stock | · | · | 38,098 | Disposed |
| Feb. 8, 2010 | JNJ | Restricted Share Units | Common Stock | · | · | 48,906 | Acquired |
| Feb. 8, 2010 | JNJ | Employee Stock Options (Right to Buy) [F3] | Common Stock | $62.62 | Feb. 8, 2020 | 586,873 | Acquired |
| Aug. 3, 2009 | JNJ | Phantom Stock Units | Common Stock | · | · | 42,410 | Disposed |
| July 15, 2009 | JNJ | Employee Stock Options (Right to Buy) [F6] | Common Stock | · | Dec. 1, 2009 | 158,200 | Disposed |
| June 30, 2009 | JNJ | Phantom Stock Units [F2] | Common Stock | · | · | 365 | Acquired |
| March 31, 2009 | JNJ | Phantom Stock Units [F4] | Common Stock | · | · | 363 | Acquired |
| Feb. 23, 2009 | JNJ | Employee Stock Option (Right to Buy) [F7] | Common Stock | · | Dec. 1, 2009 | 1,800 | Disposed |
Showing latest 100 of 163 transactions
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 13 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Aug. 7, 2025 | HTFL | Common Stock | 56,256 | Direct |
| Aug. 7, 2025 | HTFL | Stock Option | · | Direct |
| Aug. 7, 2025 | HTFL | Stock Option | · | Direct |
| Aug. 7, 2025 | HTFL | Stock Option | · | Direct |
| Aug. 7, 2025 | HTFL | Stock Option | · | Direct |
| Aug. 7, 2025 | HTFL | Stock Option | · | Direct |
| Aug. 7, 2025 | HTFL | Stock Option | · | Direct |
| Aug. 7, 2025 | HTFL | Series D Preferred Stock | · | Direct |
| Aug. 7, 2025 | HTFL | Series F Preferred Stock | · | Direct |
| Aug. 7, 2025 | HTFL | Series F-1 Preferred Stock | · | Direct |
| May 30, 2013 | XOM | Common Stock | 1,000 | Direct |
| April 1, 2013 | CVS | Common Stock | 1,000 | Direct |
| March 22, 2005 | AMJB | Common Stock | 1,000 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2012 | $1,320,578 | $0 | · | · | $13,447,666 | $3,250,000 | $234,688 | $29,838,259 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.